Position statement of the Spanish Menopause Society on the Clinical Use of Cimicifuga racemosa during menopause;Posicionamiento de la Asociación Española para el Estudio de la Menopausia sobre el uso clínico de la Cimicífuga racemosa en el climaterio

Progresos de Obstetricia y Ginecologia

Volumn 52, Issue 12, 2009, Pages 712-721

  Dolores Julia M ^a   Ferrer, Javier ^b   Quereda, Francisco ^c   Navarro, Concepción ^d   Menéndez, Carmen ^e   Mendoza, Nicolás ^f   Forteza, Andrés ^g   Castelo Branco, Camil ^h   Jesus Cornellana M ⁱ   Jesus Cancelo M ^j   Beltrán, Estanislao ^d   Ignacio Bachiller, Luis ^k   Allué, Josep ^l   Villero, José ^m   Sánchez Borrego, Rafael ⁿ   Palacios, Santiago ^e   Haya, Javier ^o   Durán, Magdalena ^h  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c Hospital Universitario   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

^e Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^g Hospital Comarcal d'Inca   (Spain)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

^j HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^k Sociedad Asturiana de Fitoterapia   (Spain)

^l UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^m HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁿ Clinica de Atencion a la Mujer   (Spain)

^o HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

more..

Author keywords

Cimicifuga racemosa; Hot flushes; Menopause; Mood

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

ARTICLE; CIMICIFUGA RACEMOSA; DRUG EFFECT; HOT FLUSH; HUMAN; INTERNET; MEDICAL SOCIETY; MEDLINE; MENOPAUSAL SYNDROME; MENTAL INSTABILITY; PHYTOTHERAPY; RELIABILITY; SYMPTOMATOLOGY; VASOMOTOR DISORDER;

EID: 73049089821     PISSN: 03045013     EISSN: 15781453     Source Type: Journal    
DOI: 10.1016/S0304-5013(09)73055-9     Document Type: Article

References (7)

1. Mahady S. Botanical dietary supplement use in peri- and postmenopausal women. Menopause 10 (2003) 65
2. Dog T.L., Powell K.L., and Weisman S.M. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 10 (2003) 299-313
3. Einer-Jensen N., Zhao J., Andersen K.P., and Kristoffersen K. Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 25 (1996) 149-153
4. Freudenstein J., Dasenbrock C., and Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res 62 (2002) 3448-3452
5. Seidlova-Wuttke D., Jarry H., Becker T., Christoffel V., and Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 44 Suppl 1 (2003) S39-S50
6. SIGN 50: a guidelines developers' handbook. Edinburgh: Scottish Intercollegiate Guidelines Neetwork; 2004.
7. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clin Trials 117 (1996) 1-12